FOOTHILL RANCH, Calif.,
Oct. 12, 2021 /PRNewswire/
-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, today announced it will host a Q&A session
and webcast for investors regarding its upcoming special meeting of
stockholders scheduled for November 19,
2021 at 10:00 am PT.
As a public company, BIOLASE believes in the importance of
transparency with investors, regardless of their size and economic
stake. To help facilitate these connections and enhance engagement,
BIOLASE is partnering with Say Technologies, a Robinhood Markets
company, that has built an innovative communication platform to
make it easier for investors to exercise their ownership rights.
BIOLASE will utilize Say Connect to solicit questions from
investors ahead of a special webcast on October 25, 2021 at 1:00
pm PT.
Starting today, investors who were holders of BIOLASE stock as
of the record date for the special meeting (the close of business
on October 1, 2021) can submit
questions to management. To submit questions, please visit the
Say Connect platform at
https://app.saytechnologies.com/biolase-2021-october. Questions
can be submitted through 3:00 pm PT
on October 19, 2021.
BIOLASE will respond to questions from investors on a webcast
scheduled for October 25, 2021 at
1:00 pm PT. A link to the webcast
will be posted to the BIOLASE investor page at
https://ir.biolase.com.
On October 8, 2021, BIOLASE
provided notice of a Special Meeting of Stockholders. More
information on the Special Meeting can be found at:
https://ir.biolase.com/news-events/biolase-special-meeting-information
About BIOLASE, Inc.
BIOLASE is a medical device company that develops,
manufactures, markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals. BIOLASE's
proprietary laser products incorporate approximately 271 patented
and 40 patent-pending technologies designed to provide biologically
and clinically superior performance with less pain and faster
recovery times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 41,200 laser systems
to date in over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information
on Waterlase iPlus®, Waterlase Express™, and
laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®,
Waterlase® and Waterlase iPlus® are
registered trademarks of BIOLASE, Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-to-host-qa-and-webcast-for-investors-regarding-its-special-meeting-of-stockholders-301398467.html
SOURCE BIOLASE, Inc.